Department of Pediatric Hematology, Emma Children's Hospital, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
Department of Child and Adolescent Psychiatry and Psychosocial Care, Emma Children's Hospital, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
Pediatr Blood Cancer. 2023 Jun;70(6):e30315. doi: 10.1002/pbc.30315. Epub 2023 Mar 30.
Pain is the clinical hallmark of sickle cell disease (SCD) leading to hospitalization, psychological sequelae and a decreased health-related quality of life. The aim of this systematic literature review is to evaluate the efficacy of non-pharmacological interventions in reducing sickle cell related pain in children with SCD.
Following the Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines, a comprehensive literature search up until October 2022 was performed to identify studies that investigated the efficacy of non-pharmacological interventions on (1) pain frequency and/or intensity, and (2) analgesic and health service use in children with SCD until the age of 21. Both randomized controlled trials (RCTs) and quasi-experimental designed (QED) studies were considered for inclusion.
Ten articles (five RCTs and five QED studies) with 422 participants were included. They investigated cognitive behavioural therapy (CBT) (n = 5), biofeedback (n = 2), massage (n = 1), virtual reality (n = 1) and yoga (n = 1). The majority of the interventions were psychological (n = 7) and were performed in the outpatient clinic (n = 6). CBT and biofeedback significantly reduced frequency and/or intensity of SCD-related pain in outpatient settings, while virtual reality and yoga significantly reduced pain in inpatient settings. Biofeedback also significantly reduced analgesic use. None of the included articles reported reduced health service use.
Non-pharmacological interventions may be effective in reducing pain in paediatric patients with SCD. However, due to the heterogeneity of the included studies a quantitative analysis could not be performed. Awaiting further supporting evidence, healthcare providers should consider implementing these interventions as valuable part of a comprehensive pain management strategy plan.
疼痛是镰状细胞病(SCD)的临床特征,导致住院、心理后遗症和健康相关生活质量下降。本系统文献综述的目的是评估非药物干预措施在减少 SCD 儿童镰状细胞相关疼痛方面的疗效。
根据系统评价和荟萃分析的首选报告项目指南,全面检索截至 2022 年 10 月的文献,以确定研究非药物干预措施对(1)疼痛频率和/或强度,以及(2)SCD 儿童至 21 岁时使用的镇痛药和卫生服务的疗效。包括随机对照试验(RCT)和准实验设计(QED)研究。
纳入了 10 篇文章(5 项 RCT 和 5 项 QED 研究),共 422 名参与者。他们研究了认知行为疗法(CBT)(n=5)、生物反馈(n=2)、按摩(n=1)、虚拟现实(n=1)和瑜伽(n=1)。大多数干预措施是心理干预(n=7),并在门诊进行(n=6)。CBT 和生物反馈在门诊环境中显著降低 SCD 相关疼痛的频率和/或强度,而虚拟现实和瑜伽在住院环境中显著降低疼痛。生物反馈还显著减少了镇痛药的使用。纳入的文章均未报告减少卫生服务的使用。
非药物干预措施可能对减少 SCD 儿科患者的疼痛有效。然而,由于纳入研究的异质性,无法进行定量分析。在等待更多支持证据的同时,医疗保健提供者应考虑将这些干预措施作为全面疼痛管理策略计划的有价值组成部分。